NJ Pharma Executive Linked to $38M Insider Trading Scheme: Prosecutors
r approval of a drug to treat COVID-19 called Lenzilumab," the DOJ alleges. According to prosecutors, Humanigen announced plans to...
Day: December 24, 2024
Cadwalader Secures Victory in Securities Class Action Lawsuit
As a finance and securities journalist, it's important to stay on top of the latest news and updates in the...
Humacyte Class Action Lawsuit Alert: Bragar Eagel & Squire, P.C. Notice
A class action lawsuit has been filed against Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA) in the United States...